180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATNF 180 Life Sciences Corp

Post-Market Trading 05-14 19:09:36 EDT

2.00

-0.02

-0.99%

盘后2.04

+0.04+2.00%

17:32 EDT

High2.17	Low1.93	Vol15.05K
Open1.99	D1 Closing2.02	Amplitude11.81%
Mkt Cap1.71M	Tradable Cap1.53M	Total Shares852.77K
T/O30.55K	T/O Rate1.97%	Tradable Shares765.13K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ATNF","market":"US","secType":"STK","nameCN":"180 Life Sciences Corp","latestPrice":2,"timestamp":1715716800000,"preClose":2.02,"halted":0,"volume":15048,"hourTrading":{"tag":"盘后","latestPrice":2.04,"preClose":2,"latestTime":"17:32 EDT","volume":56,"amount":112.35000000000001,"timestamp":1715722337958},"delay":0,"floatShares":765126,"shares":852772,"eps":-52.58689,"marketStatus":"Post-Market Trading","change":-0.02,"latestTime":"05-14 19:09:36 EDT","open":1.99,"high":2.1699,"low":1.9314,"amount":30547.5182496,"amplitude":0.118069,"askPrice":2.13,"askSize":51,"bidPrice":1.95,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-52.58689,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1715731200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.02,"preHourTrading":{"tag":"盘前","latestPrice":1.97,"preClose":2.05,"latestTime":"08:00 EDT","volume":332,"amount":663.089988,"timestamp":1715688003157},"postHourTrading":{"tag":"盘后","latestPrice":2.04,"preClose":2,"latestTime":"17:32 EDT","volume":56,"amount":112.35000000000001,"timestamp":1715722337958},"volumeRatio":0.569439},"requestUrl":"/m/hq/s/ATNF","defaultTab":"news","newsList":[{"id":"2434091619","title":"180 Life Sciences Executive Overhaul and New Indemnity Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2434091619","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434091619?lang=en_us&edition=fundamental","pubTime":"2024-05-09 20:12","pubTimestamp":1715256765,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) has shared an update. On May 7, 2024, 180 Life Sciences Corp. underwent significant executive changes, with CEO Dr. James ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-executive-overhaul-and-new-indemnity-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-executive-overhaul-and-new-indemnity-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2431081171","title":"Psychedelic drug developers could benefit from NIH funding for chronic pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2431081171","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2431081171?lang=en_us&edition=fundamental","pubTime":"2024-04-30 01:37","pubTimestamp":1714412227,"startTime":"0","endTime":"0","summary":"The National Institutes of Health recently announced it is offering $8.4M to support trials examining the efficacy and safety of psychedelic treatments for chronic pain. The notice, posted April 24, said that the research can include psilocybin , LSD, mescaline, and MDMA, also known as ecstasy.  \"A potential novel approach to treatment of chronic pain in adults involves psychedelic-assisted therapy ,\" the notice states. \"Evidence for the efficacy of PAT has been particularly notable in depression, anxiety , post-traumatic stress disorder , and substance use disorders, among other indications.\"  Marijuana Moment first reported the development on Monday. Several companies involved in developing psychedelic-based therapies could potentially benefit from the funding. These include Mind Medicine , Atai Life Sciences , Cybin , COMPASS Pathways , Lucy Scientific Discovery , 180 Life Sciences , Bright Binds Bioscience , and Seelos Theraspeutics .","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157676497/image_157676497.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157676497/image_157676497.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4095746-psychedelic-drug-developers-could-benefit--nih-funding-chronic-pain","is_publish_highlight":false,"gpt_icon":0},{"id":"2428832646","title":"SINT, ATNF and RETO among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2428832646","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428832646?lang=en_us&edition=fundamental","pubTime":"2024-04-18 00:53","pubTimestamp":1713372824,"startTime":"0","endTime":"0","summary":"Gainers: INVO Bioscience INVO+259%.Edible Garden AG EDBL+81%.SINTX Technologies (SINT) +76%.Ryde Group Ltd. (RYDE) +58%.Vanda Pharmaceuticals VNDA+34%.Cheche Group (CCG) +25%.Mercurity Fintech Holding MFH+24%.180 Life Sciences Corp (ATNF) +22%.WiSA Technologies WISA+20%.Massimo Group MAMO+19%.Losers: Iczoom Group IZM-87%.Arrowroot Acquisition Corp AILE-49%.Sunshine Biopharma SBFM-41%.Longeveron LGVN-39%.ReTo Eco-Solutions (RETO) -25%.SolarMax Technology SMXT-25%.China SXT Pharmaceuticals SXTC-24%.GameSquare Holdings GAME-23%.Sage Therapeutics SAGE-24%.Finch Therapeutics Group FNCH-23%.","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4090610-sint-atnf-and-reto-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2427829482","title":"INDO, ONVO and HUSA among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2427829482","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2427829482?lang=en_us&edition=fundamental","pubTime":"2024-04-16 20:28","pubTimestamp":1713270528,"startTime":"0","endTime":"0","summary":"Losers: Ryvyl -37%on launch of proposed underwritten public offering.Pacific Biosciences of California  -16%announces preliminary first Quarter 2024 revenue and updates 2024 revenue guidance.Live Nation Entertainment -9%on reports Justice Dept. may file antitrust lawsuit next month.More on pre-market losers & stocks.  Financial information for Houston American Energy Financial information for Indonesia Energy Financial information for Organovo Holdings Compare metrics for HUSA to INDO, ONVO","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4089998-indo-onvo-and-husa-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2422975996","title":"GOEV, CHEK and MESO among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422975996","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422975996?lang=en_us&edition=fundamental","pubTime":"2024-03-27 20:28","pubTimestamp":1711542509,"startTime":"0","endTime":"0","summary":"Losers: Direct Digital Holdings  -44% after Q4 earnings release. LuxUrban Hotels  -16% reports preliminary 2023 results. Altimmune  -31% after Q4 earnings release. Gamestop Corporation  -18% after Q4 earnings release. Mesoblast Ltd  -15%. BYND Cannasoft Enterprises  -12%. AEye  -10% reports Q4 results. Forge Global Holdings  -9% after Q4 earnings release.  Check-Cap Ltd  -7%. 180 Life Sciences Corp  -6%. OrganiGram Holdings  -5% after announcing C$25M stock offering. Canoo  -5%. Mira Pharmaceuticals  -5%. Ocean Biomedical  -5%.   More on Pre-market losers & stocks.  Canoo: Positive News Isn't Enough Canoo: Avoid After Reverse Stock Split Canoo: There Is A Glimpse Of Hope But Hold Mesoblast gains as FDA backs regulatory plans for cell therapy Check-Cap jumps on Nobul AI business combination","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4084242-goev-chek-and-meso-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0},{"id":"2422261445","title":"CGC, CYTO and IDN are among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2422261445","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422261445?lang=en_us&edition=fundamental","pubTime":"2024-03-26 01:25","pubTimestamp":1711387526,"startTime":"0","endTime":"0","summary":"Gainers: Landos Biopharma  +171%. MoneyHero  +49%. Next.  +50%. KULR Technology  +42%. Intellicheck  +31%. Altamira Therapeutics  +31%. Nkarta  +26%. XTL Biopharmaceuticals  +25%. Target Hospitality  +24%. MAIA Biotechnology  +23%.  Losers: Australian Oilseeds  -29%.  Aehr Test Systems  -27%. Vimeo  -25%. flyExclusive  -24%. Invivyd  -23%. Lobo EV Technologies  -23%. TRxADE Health  -23%. Intrusion  -24%. Canopy Growth Corporation  -21%. 180 Life Sciences  -20%.   More on mid-day movers & stock  Canopy Growth Is Climbing, But It Won't Last Intellicheck, Inc.  Q4 2023 Earnings Call Transcript Canopy Growth Corporation  Q3 2024 Earnings Call Transcript Altamira stock rallies 44% on Univercells mRNA collaboration Cannabis stocks rally as Schumer circulates petition for SAFER Banking Act","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083391-cgc-cyto-and-idn-are-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2421892847","title":"VERI, AMTX and ATNF among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2421892847","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2421892847?lang=en_us&edition=fundamental","pubTime":"2024-03-23 01:02","pubTimestamp":1711126949,"startTime":"0","endTime":"0","summary":"Gainers: IMAC Holdings  +88%. Nova Lifestyle  +58%. Intellicheck  +56%. Summit Midstream Partners LP  +34%. Canopy Growth Corporation  +36%. Veritone  +32%. GT Biopharma  +31%. Outlook Therapeutics  +28%. Austin Gold Corp  +25%.  Aemetis  +24%.  Losers: BYND Cannasoft Enterprises  -35%. Cutera  -28%. Nkarta  -28%. Ispire Technology  -26%. flyExclusive  -23%. ReTo Eco-Solutions  -21%. 180 Life Sciences Corp  -21%. Auna S.A.  -18%. Zura Bio Ltd  -16%.   More on Mid-day movers & stocks.  Veritone, Inc.  Q4 2023 Earnings Call Transcript Aemetis, Inc.  Q4 2023 Earnings Call Transcript Aemetis, Inc. 2023 Q4 - Results - Earnings Call Presentation Aemetis surges after USCIS approves $200M for renewable energy projects Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4082904-veri-amtx-and-atnf-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2418635018","title":"ETRN, CRDF and KC are among pre market gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2418635018","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2418635018?lang=en_us&edition=fundamental","pubTime":"2024-03-11 21:30","pubTimestamp":1710163853,"startTime":"0","endTime":"0","summary":"Kidpik  +281%. L.S. Starrett  +59% Enters Into a Merger Agreement With MiddleGround Capital to Become Private Company.  TC BioPharm  +57%. Unusual Machines  +34%. Auddia  +27%. Sonnet BioTherapeutics  +20% Announces Early Safety Data from the Company’s Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy  Met the Study’s Initial Pre-Specified Objective.  Mesoblast  +19% Crypto-linked stocks, MESO and more  Graphite  +16%. 180 Life Sciences  +13%. NuScale Power Corporation  +15% to Participate in March and April 2024 Investor Conferences.  AirNet Technology  +15% Announces Changes in the Board of Directors  Mawson Infrastructure Group  +14%. GDS Holdings Limited  +14%. Amplify Energy  +13% oil sheen not related to its operations.  Kingsoft Cloud Holdings  +12%. Lexeo Therapeutics  +10% Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights.  Microstrategy  +10%. Marpai  +9%. Revelation Biosciences  +9%. Cardiff Oncology  +9%","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/522334235/image_522334235.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4077980-etrn-crdf-and-kc-are-among-pre-market-gainers","is_publish_highlight":false,"gpt_icon":0},{"id":"2418454330","title":"180 Life Sciences Board Reshuffle and Strategic Refocus","url":"https://stock-news.laohu8.com/highlight/detail?id=2418454330","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2418454330?lang=en_us&edition=fundamental","pubTime":"2024-03-11 19:12","pubTimestamp":1710155539,"startTime":"0","endTime":"0","summary":"An announcement from 180 Life Sciences (ATNF) is now available. On March 7, 2024, 180 Life Sciences Corp. announced the resignation of Sir Marc Fel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-board-reshuffle-and-strategic-refocus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-board-reshuffle-and-strategic-refocus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2414835151","title":"InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Plans 1-for-19 Reverse Stock Split to Regain NASDAQ Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2414835151","media":"StreetInsider","top":-1,"share":"https://ttm.financial/m/news/2414835151?lang=en_us&edition=fundamental","pubTime":"2024-02-26 23:10","pubTimestamp":1708960200,"startTime":"0","endTime":"0","summary":"InvestorWire  is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers:  access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries;  article and editorial syndication to 5,000+ outlets;  enhanced press release enhancement to ensure maximum impact;  social media distribution via IBN to millions of social media followers; and  a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22830957","is_publish_highlight":false,"gpt_icon":0},{"id":"2414883606","title":"180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2414883606","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2414883606?lang=en_us&edition=fundamental","pubTime":"2024-02-26 20:00","pubTimestamp":1708948800,"startTime":"0","endTime":"0","summary":"PALO ALTO, Calif., Feb. 26, 2024  -- 180 Life Sciences Corp.  , today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-19 . The Reverse Stock Split is expected to become effective on February 28, 2024 at 12:01 p.m. Eastern Time , with shares expected to begin trading on the Nasdaq Capital Market, on a split-adjusted, at market open on February 28, 2024. In connection with the Reverse Stock Split, every 19 shares of the Company’s common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company’s common stock. No change will be made to the trading symbol for the Company’s shares of common stock or public warrants, “ATNF” and “ATNFW”, respectively, in connection with the reverse split.Additional information regarding the reverse stock split is available in the Company’s definitive proxy statement originally filed with the U.S. Securities and Exchange Commission  on D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/180-life-sciences-corp-announces-120000851.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2412174971","title":"180 Life Sciences Wins Interim Legal Cost Coverage Ruling","url":"https://stock-news.laohu8.com/highlight/detail?id=2412174971","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2412174971?lang=en_us&edition=fundamental","pubTime":"2024-02-20 21:13","pubTimestamp":1708434802,"startTime":"0","endTime":"0","summary":"180 Life Sciences (ATNF) has released an update. A recent court ruling has favored 180 Life Sciences Corp. in its litigation by ordering two insure...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-wins-interim-legal-cost-coverage-ruling?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/180-life-sciences-wins-interim-legal-cost-coverage-ruling?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2411822300","title":"Psychedelic stocks gain after FDA priority review for MDMA therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2411822300","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2411822300?lang=en_us&edition=fundamental","pubTime":"2024-02-13 01:13","pubTimestamp":1707758012,"startTime":"0","endTime":"0","summary":"Companies focused on psychedelic medicines traded higher on Monday after the FDA granted priority review for midomafetamine capsules (MDMA), which, if approved, could become the first psychedelic-assi","market":"us","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4065641-psychedelic-stocks-gain-fda-priority-review-mdma-therapy","is_publish_highlight":false,"gpt_icon":0},{"id":"2404553413","title":"BRIEF-180 Life Sciences Took Various Actions To Reduce Compensation Payable To Certain Of Its Service Providers","url":"https://stock-news.laohu8.com/highlight/detail?id=2404553413","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2404553413?lang=en_us&edition=fundamental","pubTime":"2024-01-17 21:39","pubTimestamp":1705498764,"startTime":"0","endTime":"0","summary":"Jan 17 (Reuters) - 180 Life Sciences Corp   :   * 180 LIFE SCIENCES CORP - EFFECTIVE ON JAN 1, TOOK VARIOUS ACTIONS TO REDUCE COMPENSATION PAYABLE TO CERTAIN OF ITS SERVICE PROVIDERS TO CONSERVE CASHFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402471479","title":"US Stocks Higher; Inflation Rate Increases To 3.4% In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2402471479","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2402471479?lang=en_us&edition=fundamental","pubTime":"2024-01-11 23:44","pubTimestamp":1704987895,"startTime":"0","endTime":"0","summary":"U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 50 points on Thursday.\n\nFollowing the market opening Thursday, the Dow traded up 0.07% to 37,723.53 while the NASDAQ rose 0.46% to 15,039.09. The S&amp;P 500 also rose, gaining, 0.21% to 4,793.32.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/01/36594814/us-stocks-higher-inflation-rate-increases-to-3-4-in-december","is_publish_highlight":false,"gpt_icon":0},{"id":"2391693034","title":"BRIEF-180 Life Sciences , Nasdaq Provided Company Written Notice That Company Has Complied With Terms Of Prior Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2391693034","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2391693034?lang=en_us&edition=fundamental","pubTime":"2023-12-15 21:33","pubTimestamp":1702647225,"startTime":"0","endTime":"0","summary":"Dec 15 (Reuters) - 180 Life Sciences Corp   :   * 180 LIFE SCIENCES CORP - ON DECEMBER 14, 2023, NASDAQ PROVIDED COMPANY WRITTEN NOTICE THAT COMPANY HAS COMPLIED WITH TERMS OF PRIOR EXTENSIONSource text for Eikon: [ Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.180lifesciences.com","stockEarnings":[{"period":"1week","weight":0.0802},{"period":"1month","weight":-0.0648},{"period":"3month","weight":-0.4935},{"period":"6month","weight":-0.7046},{"period":"1year","weight":-0.8904},{"period":"ytd","weight":-0.502}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":-0.003707},{"month":2,"riseRate":0.571429,"avgChangeRate":0.023231},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.068224},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.010361},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.056894},{"month":6,"riseRate":0.833333,"avgChangeRate":-0.043416},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.018654},{"month":8,"riseRate":0,"avgChangeRate":-0.107399},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.05242},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.093397},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.139077},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.167848}],"exchange":"NASDAQ","name":"180 Life Sciences Corp","nameEN":"180 Life Sciences Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 180 Life Sciences Corp(ATNF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"180 Life Sciences Corp,ATNF,180 Life Sciences Corp股票,180 Life Sciences Corp股票老虎,180 Life Sciences Corp股票老虎国际,180 Life Sciences Corp行情,180 Life Sciences Corp股票行情,180 Life Sciences Corp股价,180 Life Sciences Corp股市,180 Life Sciences Corp股票价格,180 Life Sciences Corp股票交易,180 Life Sciences Corp股票购买,180 Life Sciences Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"180 Life Sciences Corp(ATNF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 180 Life Sciences Corp(ATNF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction